Hiromi Okabe
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Epidemiology
- Pharmacology top 5%
- Co-authors
- Yukiya HashimotoHirofumi SatakeHitoshi SaitôK NakanoTetsuhiko ShirasakaJunji UchidaA FujiokaSetsuo Takeda
- Topics
- Influenza Virus Research Studies (4 papers)Pharmacological Effects and Toxicity Studies (4 papers)Pharmacogenetics and Drug Metabolism (4 papers)
- Cited by
- OncologyPharmacologyTransplantation
- Partner nations
- JapanUnited States
In The Last Decade
Hiromi Okabe
16 papers receiving 621 citations
Peers
Comparison fields: 5 of 72
- Oncology 316
- Pulmonary and Respiratory Medicine 214
- Molecular Biology 123
- Epidemiology 112
- Pharmacology 89
Countries citing papers authored by Hiromi Okabe
This map shows the geographic impact of Hiromi Okabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromi Okabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromi Okabe more than expected).
Fields of papers citing papers by Hiromi Okabe
This network shows the impact of papers produced by Hiromi Okabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromi Okabe. The network helps show where Hiromi Okabe may publish in the future.
Co-authorship network of co-authors of Hiromi Okabe
This figure shows the co-authorship network connecting the top 25 collaborators of Hiromi Okabe. A scholar is included among the top collaborators of Hiromi Okabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromi Okabe. Hiromi Okabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 28 | |
| 4 | 11 | |
| 5 | 56 | |
| 6 | 15 | |
| 7 | 37 | |
| 8 | 20 | |
| 9 | 28 | |
| 10 | 16 | |
| 11 | 35 | |
| 12 | 32 | |
| 13 | Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 2nd communication: absorption, distribution and excretion after single and consecutive subcutaneous administration in rats. | 1 |
| 14 | Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man. | 4 |
| 15 | Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats. | 335 |
| 16 | 17 |
About Hiromi Okabe
Hiromi Okabe is a scholar working on Pharmacology, Transplantation and Biotechnology, having authored 16 papers that have together received 640 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (4 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Oncology (316 citations), Pharmacology (89 citations) and Transplantation (23 citations). Hiromi Okabe has collaborated with scholars based in Japan and United States. Frequent co-authors include Yukiya Hashimoto, Hirofumi Satake, Hitoshi Saitô, K Nakano, Tetsuhiko Shirasaka, Junji Uchida, A Fujioka, Setsuo Takeda, M Fukushima and Norio Unemi. Their work appears in journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.